InMode Ltd INMD reported Q2 sales of $136.1 million, an increase of 20% Y/Y, beating the consensus of $132 million and slightly above the preliminary numbers. Adjusted EPS reached $0.72, compared to ...
On a *non-GAAP basis, InMode reported net income of $24.5 million, or $0.38 per diluted share, in the third quarter of 2025, compared to $55.0 million, or $0.70 per diluted share, in the third quarter ...
InMode Ltd. boasts superior fundamentals, yet trades at undervalued market multiples due to its unique risk profile. The company is a leader in the global aesthetics market with proprietary RF-based ...
InMode is a medical device maker that specializes in minimally invasive treatments with results that resemble those of liposuction. The average price target on Wall Street for InMode represents a 47% ...
A lot of (digital) ink tends to get spilled about how much businesses grow their revenues each quarter. But sometimes, like with InMode's (NASDAQ: INMD) second-quarter earnings, the most exciting ...
InMode Ltd INMD shares are trading lower by over 20% after the company issued Q3 guidance below estimates and lowered FY23 revenue guidance. The company expects Q3 revenue of $122.8 million-$123.0 ...
YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...
On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash.
We are writing to make you aware that we have expressed interest to InMode’s leadership in pursuing an acquisition by Steel Partners of 51% of the Company’s outstanding shares for $18.00 per share, ...
InMode's CFO says a multi-year demand downturn is beginning to stabilize and management is targeting 2026 revenue to be "flat", while noting patient demand is the primary headwind and higher interest ...
On Wednesday, 11 March 2026, InMode Ltd (NASDAQ:INMD) presented its strategic vision at the Barclays 28th Annual Global Healthcare Conference. The company, navigating a challenging market environment, ...
InMode's customers need to buy consumable products to use with their devices. The more consumables the company sells, the more recurring revenue it gets. Sales of its consumables are rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results